Bloomage BioTechnology's high P/E ratio could face pressure ...
Bloomage BioTechnology's high P/E ratio could face pressure due to weak earnings outlook and slower growth. Overly bullish investors refusing to sell at current prices may face future disappointment.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more